Artificial intelligence in early drug discovery enabling precision medicine

Area of Science:

• Biomedical Science
• Computational Biology
• Pharmacology

Background:

• Precision medicine tailors treatments to individual patient profiles, including lifestyle and molecular data.
• Current precision medicine in drug discovery relies on limited biomarkers, hindering the use of comprehensive patient molecular data.
• The future of healthcare involves deep multi-omics characterization of patients, necessitating advanced analytical methods.

Purpose of the Study:

• To review the current state of drug discovery within precision medicine.
• To present a vision for the impact of artificial intelligence on biomarker discovery and drug design.
• To highlight the potential of AI in personalizing medicine.

Main Methods:

• Review of current literature on precision medicine and drug discovery.
• Analysis of the role of artificial intelligence in biomarker identification.
• Discussion of AI applications in tailoring drug design to patient molecular heterogeneity.

Main Results:

• Precision medicine offers increased clinical trial success rates and accelerated drug approvals.
• Artificial intelligence is essential for analyzing deep multi-omics patient data.
• AI algorithms are key to developing personalized drug regimens.

Conclusions:

• Artificial intelligence represents the next frontier in precision medicine, enabling a fully personalized approach.
• AI will revolutionize drug design by leveraging comprehensive patient molecular profiles.
• The integration of AI in precision medicine will significantly impact clinical practice and patient outcomes.